Arkolith/Insider Trading/LUNG/Form 4

French Glendon E. III

President and CEO, DirectorPulmonx Corp (LUNG) · full profile →Form 4 · filed Dec 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2025Sell(S)3K$1.57$4K284K
Dec 1, 2025Grant(A)1.2M—$01.5M
Dec 1, 2025Sell(S)6K$1.57$10K277K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 1, 2025Grant(A)800K—$0800K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001805624-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML